(Table 1) Moreover, the presence of combined MYC dysregulation, and BCL2 upregulation at diagnosis already predicted a very aggressive clinical course with rapid transformation into a high-grade lymphoma [4]. The gene discussed is MYC; the disease is lymphoma.